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Background: Short-term (<1 week) muscle disuse lowers daily myofibrillar protein synthesis 2 
(MyoPS) rates resulting in muscle mass loss. The understanding of how daily dietary protein 3 
intake influences such muscle deconditioning requires further investigation. Objective: To 4 
assess the influence of graded dietary protein intakes on daily MyoPS rates and the loss of 5 
muscle mass during 3 days of disuse. Design: 33 healthy young men (age, 22±1 y; BMI, 23±1 6 
kg·m-2) first consumed the same standardized diet for 5 days providing 1.6 g protein·kg bm·d-7 
1. Thereafter, participants underwent a 3 day period of unilateral leg immobilization during 8 
which they were randomized into one of three eucaloric diets containing a relatively high, low, 9 
or no protein at all (HIGH: 1.6, LOW: 0.5, NO: 0.1 g·kg bm·d-1; n=11 per group). One day 10 
prior to immobilization participants ingested 400 mL deuterated water (D2O) with 50 mL doses 11 
consumed daily thereafter. Prior to and immediately after immobilization upper leg bilateral 12 
MRI scans and M. vastus lateralis biopsies were performed for the measurements of M. 13 
quadriceps volume and daily MyoPS rates, respectively. Results: M. quadriceps volume of 14 
the control legs remained unchanged throughout the experiment (P>0.05). Immobilization led 15 
to 2.3±0.4, 2.7±0.2 and 2.0±0.4% decreases in M. quadriceps volume (P<0.05) of the 16 
immobilized leg in the HIGH, LOW and NO groups (P<0.05), respectively, with no significant 17 
differences between groups (P>0.05). D2O ingestion resulted in comparable plasma free 2H-18 
alanine enrichments during immobilization (~2.5 MPE) across groups (P>0.05). Daily MyoPS 19 
rates during immobilization were 30±2 (HIGH), 26±3 (LOW) and 27±2 (NO) % lower in the 20 
immobilized compared with control leg, with no significant differences between groups 21 
(P>0.05). Conclusions: Three days of muscle disuse induces considerable declines in muscle 22 
mass and daily MyoPS rates. However, daily protein intake does not modulate any of these 23 
muscle deconditioning responses.  24 






Recovery from illness or injury often requires a period of muscle disuse, which typically occurs 27 
in the form of bed rest or limb immobilization. Recent research has focussed on short term 28 
periods of muscle disuse (≤ one week) which are common in clinical settings (1). We and others 29 
have shown that merely 2-5 days of disuse already results in substantial loss of muscle mass 30 
(2, 3, 4, 5), with associated declines in strength (3, 4, 5). As a result, there is an eagerness of 31 
researchers to develop effective (nutritional) countermeasures (e.g. 6, 3, 7). 32 
Skeletal muscle mass loss must ultimately be underpinned by a chronic imbalance between 33 
muscle protein synthesis (MPS) and breakdown (MPB) rates. We have previously shown that 34 
postabsorptive and postprandial MPS rates decline within a few days of disuse (5). This 35 
translates to chronically lower free-living daily myofibrillar protein synthesis (MyoPS) rates 36 
during disuse, an effect that manifests within just two days and can explain a large part of 37 
muscle atrophy (4). Dietary protein ingestion stimulates MPS rates and inhibits MPB rates 38 
which, under normal conditions, allows for postprandial net protein accretion within muscle 39 
tissue (8). As a consequence it has been speculated that increasing dietary protein consumption 40 
during a period of disuse may alleviate the loss of muscle mass (9, 10). However, we recently 41 
showed substantial declines in daily MyoPS rates and muscle disuse atrophy despite 42 
participants reporting relatively high habitual dietary protein intakes (1.6 g·kg bm·d-1) (11). 43 
Though this would theoretically have provided sufficient dietary protein to stimulate MyoPS 44 
rates throughout the day (12, 13) and limit muscle atrophy (10, 14), observed rates of muscle 45 
loss were in line with the literature (15, 16). 46 
Studies where essential/branched chain amino acid (EAA/BCAA) or protein supplementation 47 
has been applied during more prolonged disuse report inconsistent findings concerning loss of 48 
muscle mass and function. For example, high dose EAA/BCAA supplementation during 6-28 49 





strength and/or whole body nitrogen (17, 18, 19). However, studies where dietary protein 51 
supplementation has been applied during 5-60 days of immobilization or bed-rest have 52 
typically shown no effect on losses of muscle mass or function (3, 20). For the development of 53 
effective nutritional countermeasures, it is important to develop a clear picture of how daily 54 
dietary protein intake per se (rather than supplementation) influences muscle protein 55 
metabolism and mass during disuse. To date, no studies have manipulated total habitual dietary 56 
protein consumption under controlled dietary conditions during (short-term) disuse to establish 57 
the link between dietary protein intake, daily MyoPS rates and muscle atrophy. 58 
In the present work we conducted a dose-response study comparing how high (1.6 g·kg bm·d-59 
1), low (0.5 g·kg bm·d-1) and negligible (0.15 g·kg bm·d-1) daily dietary protein intakes 60 
influence daily MyoPS rates determined using the deuterated water approach, and muscle mass 61 
loss determined via MRI during a three day period of unilateral leg immobilization in healthy 62 
males. We hypothesised that declining dietary protein intakes would lead to a greater decline 63 


















Participants and general screening 78 
Thirty-three healthy young men (age; 21±1 y, BMI; 23±1 kg·m-2) were included in the present 79 
study (see Table 1 for participants’ characteristics) and participated in this parallel group 80 
randomized controlled trial. The trial was conducted between November 2018 and December 81 
2019 within the Nutritional Physiology Unit at the Department of Sport and Health Sciences at 82 
the University of Exeter, Exeter, UK (for the consort flow chart please see Supplemental 83 
Figure 1). Participants were allocated sequential numbers at the time of screening which were 84 
then used as the only identifiable characteristic for all documents containing participant 85 
information, and were randomised into groups using an online randomiser 86 
(http://www.randomization.com/), recruitment and testing was ended once the trial was fully 87 
recruited according to the a priori calculation. Participants attended the laboratory for a routine 88 
medical screening and completed a general medical questionnaire to assess their eligibility for 89 
participation, and to ensure no adverse health conditions were present. Exclusion criteria 90 
included; a (family) history of deep vein thrombosis/cardiovascular disease, metabolic 91 
disorders (e.g. type 2 diabetes), musculoskeletal/orthopedic disorders, a body mass index of 92 
above 28.5 or below 18.5 kg·m-2, participation in a structured resistance training program 93 
within 6 months prior to the study, any musculoskeletal injury of the legs within 12 months 94 
before the study, use of anticoagulants, any contraindications to MRI scanning (e.g. metallic 95 
implants), and consumption of any nutritional supplement prior to and during the study. 96 
Participants who consumed a habitual dietary protein intake of above 1.8 or below 0.6 g·kg·d-97 
1 were also excluded from the study. During the screening participants’ height, body mass and 98 
blood pressure were measured, body composition was also assessed by air displacement 99 





completed the International Physical Activity Questionnaire (IPAQ). This was used to estimate 101 
the participants’ physical activity level by reporting time spent sedentary, or undertaking light, 102 
moderate and vigorous activities, and multiplying this by the metabolic equivalents for these 103 
activities (METs) (21). Participants’ habitual diets were recorded for 3 days (two week days 104 
and one weekend day) prior to the dietary controlled period by a self-reported written diet diary 105 
following detailed instructions and advice from a member of the research team. Furthermore, 106 
participants visited the laboratory shortly after the screening where they were familiarized to 107 
the exercise tests (described below). All participants were informed of the nature and possible 108 
risks of the experimental procedures before providing written informed consent. The study was 109 
approved by The Sport and Health Science Ethics committee of the University of Exeter 110 
(170712/B/01), in accordance with the guidelines set out in the Declaration of Helsinki, and 111 
registered as a clinical trial with clinicaltrials.gov (NCT03797781). 112 
 113 
Experimental protocol 114 
A graphical representation of the study design is shown in Figure 1. Following acceptance 115 
onto the study participants attended the laboratory in the fasted state for 5 experimental visits 116 
across 13 days. This included an 8 day fully controlled dietary intervention period with the 117 
final 3 days of the dietary controlled period involving unilateral leg immobilization using a leg 118 
brace and ambulation with crutches. Pre-immobilization (visit 1) comprehensive unilateral 119 
muscle strength and maximal aerobic capacity (V̇O2peak) testing were conducted (protocols 120 
described below). Thereafter, five days prior to immobilization (visit 2) all participants 121 
attended the laboratory to collect their first 5 days of food to commence a fully controlled, pre-122 
immobilization standardized diet with protein intake fixed at 1.6 g·kg bm·d-1. To measure daily 123 
myofibrillar protein synthesis (MyoPS) rates throughout the immobilization period participants 124 





day prior to commencing immobilization). This protocol was designed to achieve and maintain 126 
0.8-1.0% body water deuterium enrichment during the measurement periods in line with our 127 
previous work (11, 22). The following day (visit 4) participants arrived at the laboratory at 128 
~0800 h and a single M. vastus lateralis muscle biopsy was obtained from the (to be) 129 
immobilized leg. Following this, participants were transported to an MRI scanner by 130 
wheelchair, avoiding any weight bearing activity and underwent a pre-immobilization MRI 131 
scan of both thigh muscles. Thereafter, participants were randomised, in a single (participant) 132 
blind manner into one of three isoenergetic dietary controlled experimental groups (n=11 per 133 
group) where protein intakes differed between groups; 1.6 (HIGH), 0.5 (LOW) or 0.15 (NO) 134 
g·kg bm·d-1. Participants were fitted with a leg brace to induce immobilization of one leg and 135 
were given crutches for ambulation, and provided with 3 days of food supply in line with their 136 
allotted diet, and this signified the commencement of the 3 day immobilization period. 137 
Following the immobilization period participants returned to the laboratory for the final visit 138 
(visit 5) where M. vastus lateralis muscle biopsies were collected from both the immobilized 139 
and control legs (the brace was only removed for the biopsy, MRI and exercise testing 140 
procedures). Muscle biopsies were all obtained under local anaesthesia, using the percutaneous 141 
Bergstrom needle biopsy technique (23) from the M. vastus lateralis approx. 15 cm above the 142 
patella and approx. ~2 cm below the fascia. Immediately following muscle biopsies, the tissue 143 
was quickly assessed and any blood or non-muscle tissue was dissected and discarded. The 144 
muscle samples were immediately frozen in liquid nitrogen within one min and stored at -80°C 145 
until further analysis. Thereafter, participants were transported via wheel chair to undergo 146 
further MRI scans of the thighs of both legs, and finally further unilateral 1RM strength and 147 
V̇O2peak testing of both legs separately was performed. This signified the end of the 148 






Physical activity and habitual dietary intake 151 
For 3 days prior to immobilization (days 2-5 of the pre-immobilization diet) and for the entirety 152 
of the immobilization period participants’ physical activity was measured using an 153 
accelerometer (GENEactiv, Activinsights, Cambridgeshire, UK) worn on the non-dominant 154 
wrist. Participants were instructed to wear the accelerometer continuously with data being 155 
collected at a 60 Hz sampling frequency. Participants’ were instructed to refrain from vigorous 156 
physical activity during immobilization but to attempt to maintain their habitual activity levels 157 
despite using crutches for ambulation (to avoid whole body sedentariness during 158 
immobilization). Physical activity data from the GENEActiv accelerometers were converted 159 
into 60 s epochs and used to estimate time spent performing light, moderate and vigorous 160 
physical activity using standard cut-off points (11). Participants were asked to refrain from 161 
alcohol intake for one week before and throughout the 8 day dietary control period. Dietary 162 
analyses for the calculation of habitual energy and macronutrient intakes were completed using 163 
specialized nutrition software (Nutritics Professional Nutritional Analysis Software; Swords, 164 
Co. Dublin). 165 
 166 
Magnetic resonance imaging for determination of M. quadriceps volume 167 
Prior to and post immobilization muscle volume of the M. quadriceps of both legs was 168 
determined via MRI. We described the MRI methodology for the determination of M. 169 
quadriceps volume in detail previously (11). In brief, a 1.5 tesla (T) MRI scanner was used to 170 
make axial plane images over the full length of the femur. A T1-weighted 3D turbo spin echo 171 
sequence was used (field of view 500 x 500 mm, reconstructed matrix 512 x 512 mm, echo 172 
time 15 ms, repetition time 645 ms, slice thickness 5 mm, slice gap 5 mm) with the subject 173 
lying still in the supine position, and a 4-element sense body radiofrequency coil was wrapped 174 





the bottom 25% (from the lateral femoral condyle working proximally) and top 25% (from the 176 
greater trochanter working distally) excluded (7, 18). All other images in the axial plane in the 177 
middle 50% area of the M. quadriceps were analysed via manual segmentation using Philips 178 
on-line MRI software. The same experimenter (SPK) performed all manual segmentation of 179 
the images. We (11) and others (24) have shown that this region of the M. quadriceps muscle 180 
undergoes rapid atrophy during disuse and accounts for the vast majority of total M. quadriceps 181 
volume loss. M. quadriceps volume was calculated using a previously published method (25) 182 
where the total CSA for all images was calculated and multiplied by the slice gap plus the 183 
distance between slices (linear interpolation) (in this case a total 2 cm, comprised of a 5 mm 184 
slice thickness and a 15 mm slice gap), summarized by the following equation:  185 




Deuterated water protocol 188 
The deuterated water dosing protocol was based on our previous work (4, 22). Day 1 of the 189 
experimental protocol acted as a D2O loading day where participants consumed 400 mL 70% 190 
D2O separated over the day as 8 x 50 mL boluses (CK Isotopes Ltd, Leicestershire, UK). Upon 191 
arrival at the laboratory (0730 h) background blood and saliva samples were collected before 192 
the first bolus of D2O was ingested. The first dose of D2O was consumed at ~0800 h with the 193 
remaining doses being consumed every 1.5 h thereafter. Participants stayed at the university 194 
until 4 out of the 8 loading day D2O doses had been consumed, with the remaining D2O doses 195 
being consumed at home under instruction of timings (i.e. leaving 1.5 h between each). Every 196 
day following the loading day participants consumed a maintenance dose of D2O (50 mL) upon 197 
waking (~0800 h). Blood samples were collected during the test days (i.e. day 5 [pre], 7 [after 198 
2 days of immobilization] and 12 [post]). Venous blood samples were collected from the 199 





centrifuged at 2,500 g for 10 min at 4°C. Aliquots of plasma were frozen in liquid nitrogen and 201 
stored at -80°C until further analysis took place. To ensure uniformity and compliance with the 202 
D2O protocol participants were provided with a log to record the times they consumed the D2O 203 
and were provided with enough doses to last until their next study visit, at which point 204 
containers were returned, counted and subsequent doses were provided. 205 
 206 
Muscle strength and single leg cycling V̇O2peak testing  207 
Unilateral knee extension and flexion contractions were performed using isokinetic 208 
dynamometry (Biodex System 3, Shirley, NY, USA).  Isometric, isokinetic concentric and 209 
isokinetic eccentric strength for both knee extension (i.e. M. quadriceps strength) and flexion 210 
(i.e. M. hamstrings strength) were all determined in the stated order.  After warm-up repetitions 211 
at 50, 75 and 85 % of self-determined one repetition maximum (1-RM) participants performed 212 
3 x 3 s maximal isometric repetitions of knee extension followed by knee flexion. Knee angle 213 
was fixed at 60° of flexion (0° being full extension) and repetitions were separated by a 2 214 
minute rest and the 2 exercise modalities by a 5 minute rest. Subsequently participants 215 
performed 5 repetitions of maximal knee extension isokinetic concentric exercises, and this 216 
was repeated for knee extension isokinetic eccentric exercises. Repetitions were sequential 217 
with a 2 minute break between the two contraction types, contraction speed was 60°·s-1 over 218 
the central 80° range of motion (verified by goniometry) out of each participant’s full range of 219 
motion (e.g. from full extension to full flexion). Then following a 5 minute break the same 220 
isokinetic concentric and eccentric contractions were repeated for knee flexion. 221 
Unilateral leg peak maximal oxygen uptake (V̇O2peak) was assessed using a previously  222 
validated single leg ramp exercise test to exhaustion (27, 28). In brief, a custom designed 223 
counterweight pedal (11.4 kg) was fitted to the crank of an electronically braked cycle 224 





the non-exercising leg resting on a stationary stool. The counterweight assisted with the 226 
upstroke of the cycling phase and eliminated the need to pull up on the pedal. Whole body 227 
expired gases were collected via a facemask and oxygen consumption was measured using an 228 
online gas analyser (Cortex Metalyzer 3B gas analyser, Cortex, Germany). For all exercises 229 
the (to be) immobilized leg was always performed first followed by the control leg. 230 
 231 
Dietary control 232 
Nutritional information for the pre-immobilization (5 days immediately before immobilization) 233 
and immobilization (3 day immobilization period) diets is provided in Table 2. Basal metabolic 234 
rate (BMR) was estimated using the Henry equations based on age, gender, and weight (29). 235 
Individual energy requirements were then calculated by multiplying the participants’ BMR and 236 
PAL (calculated from the IPAQ as described above). Thereafter, an individual 8 day meal plan 237 
was designed for each participant with all food prepared, weighed and packaged in-house in 238 
the Nutritional Physiology Unit’s research kitchen facility. Throughout the study all ingredients 239 
and instructions/information for preparation were provided to the participants which they 240 
prepared at home, and a log was provided to record the times of consumption of each meal. 241 
For the first 5 days of the 8 day dietary control (i.e. pre-immobilization period) all participants 242 
consumed a diet containing 1.6 g·kg bm·d-1, with ~30% of their energy being provided by fat 243 
and the remainder from carbohydrates (~50–55%; variation due to different energy 244 
requirements in parallel with clamped protein intake). Alcohol consumption and any other food 245 
or drinks (except water, but including tea and coffee) other than that provided were prohibited 246 
during the study. Dietary protein intake was equally distributed across four meals (~27±1, 247 
28±1, 28±1 and 28±1 g at breakfast, lunch, dinner and a pre-sleep whey protein beverage) and 248 
participants were instructed to consume their meals approximately 4-5 h apart, throughout the 249 





participants’ body mass was measured (seca 703 column scale, seca GmbH & Co. KG, 251 
Hamburg, Germany) wearing light clothing and the researchers discussed with the participants 252 
any questions or issues that may have arisen with the diet, and in the event of any substantial 253 
weight change (>0.5 kg, with the same upward or downward trend on two consecutive visits) 254 
energy content of the next two days was adjusted (via the reduction/increase in carbohydrate). 255 
Following the 5 day pre immobilization period, volunteers commenced with the 3 day 256 
immobilization period during which volunteers were randomised into either the HIGH (1.6 257 
g·kg bm·d-1; n=11) LOW (0.5 g·kg bm·d-1; n=11) or NO (0.15 g·kg bm·d-1; n=11) protein 258 
groups. The HIGH group therefore maintained the pre-immobilization diet precisely, whereas 259 
the LOW group had ~68% (~77 g) of their protein (and ~7% [~7 g] of fat) replaced by ~25% 260 
(~85 g) more carbohydrate, and the NO protein group had ~91% (~106 g) of their protein (and 261 
~13% [~12 g] of fat) replaced by ~45% (~164 g) of carbohydrate. The amounts of dietary 262 
protein were selected to represent a wide spectrum to allow a true dose-response to be 263 
investigated. 1.6 g·kg bm·d-1 was selected as ‘high’ based on being double the UK RDA (32), 264 
being in line with current recommendations for restricting muscle loss during disuse (10, 14, 265 
33) and also consistent with habitual protein intakes reported in our previous work investigating 266 
daily MPS rates and muscle disuse atrophy in young, healthy men (4) The LOW group was 267 
selected as 0.5 g·kg bm ·d-1 since this is considerably below (38%) the current RDA and also 268 
representative of dietary protein intakes that might be expected in patients undergoing a period 269 
of disuse in a hospital setting (34). The NO group was designed to remove dietary protein as a 270 
stimulus for MPS rates as far as possible while being practically achievable during a diet 271 
maintaining energy balance (i.e. 0.15 g·kg bm·d-1). All food items in the 1.6 and 0.5 g·kg bm·d-272 
1 protein groups were purchased from commercial retailers. To reduce protein intake to 0.15 273 
g·kg bm·d-1 certain food products given to this group were purchased from a company that 274 





meals on each diet consisted of the following: breakfast; scrambled eggs and beans on toast 276 
(HIGH), jam on toast (LOW), low protein oatmeal (NO); lunches; a chicken sandwich with 277 
snacks (e.g. biscuits, fruit) (HIGH), ham sandwich with fruit (LOW) and vegetable soup with 278 
low protein bread rolls (NO); dinner; chicken tikka masala curry with rice and vegetables 279 
(onion, green beans, tomatoes) (HIGH), vegetarian stir fry (vegetables, stir fry sauce and rice 280 
noodles) (LOW), vegetarian pizza (low protein pizza base, vegetables [sweetcorn, mushrooms, 281 
tomatoes, onion, pepper], tomato puree) (NO). 282 
 283 
Immobilization protocol 284 
We have previously used the knee brace approach to achieve unilateral leg immobilization and 285 
consequent declines in daily MPS rates and muscle mass over 2 and 7 days (11). Briefly, the 286 
brace (X-ACT Donjoy brace, DJO global, Vista, CA, USA) was applied and the participant 287 
can then ambulate on crutches (after receiving instructions) throughout the immobilization 288 
period. The immobilized leg was randomized and counterbalanced for leg dominance with the 289 
non-immobilized leg acting as a within-subject control (for both MPS rates and muscle mass 290 
measurements). Using the hinge of the brace the knee was fixed at an angle of 40° flexion (full 291 
knee extension = 0°) to ensure no weight bearing occurred. Participants were instructed that all 292 
ground contact, and muscle contraction (except for ankle rotation exercises twice per day to 293 
activate the venous muscle pump), in the immobilized leg were forbidden. Adhesive tape with 294 
the experimenter’s signature inscribed was placed around the straps of the brace. Breaking of 295 
the tape would indicate that the brace had been altered and resulted in exclusion from the study 296 
(11, 35), though it was not necessary to exclude any participants based on this in the present 297 
study. A plastic shower cover was provided to the participants to wear over the brace when 298 
showering. Daily contact was maintained with the subject throughout the study to ensure proper 299 






Plasma free [2H]alanine enrichments 302 
Plasma amino acid enrichments were determined by gas chromatography-mass spectrometry 303 
analysis (GC-MS; Agilent 5975C MSD & 7890A GC, Wilmington, USA). First the plasma 304 
samples were deproteinized using dry 5-sulfosalicylic acid. Subsequently free amino acids 305 
were purified using cation exchange chromatography (AG 50W-X8 resin, mesh size 100-200 306 
µm, ionic form: hydrogen; Bio-Rad Laboratories, Hercules, CA). The purified amino acids 307 
were converted to their tert-butyldimethylsilyl (tert-BDMS) derivatives with MTBSTFA 308 
before analysis via GC-MS. The plasma free alanine mass isotopomers (M and M+1) were 309 
measured using selective ion monitoring at m/z 232 and 233. Standard regression curves were 310 
applied from a series of known standard enrichment values against the measured values to 311 
assess the linearity of the mass spectrometer and to account for any isotope fractionation.  312 
 313 
Myofibrillar bound 2H alanine enrichments 314 
Myofibrillar protein-enriched fraction was extracted from ~50 mg of wet weight muscle tissue 315 
by hand-homogenization on ice using a pestle in a standard extraction buffer (670 µL 1M 316 
Sucrose, 500 µL 1M Tris/HCl, 500 µL 1M KCl, 100 µL 1M EDTA and ddH2O was added until 317 
a total volume of 10 ml was achieved [10 µL/mg]). The samples were centrifuged at 2,500 g 318 
and 4°C for 5 min and the pellet was then washed with 500 µL of ddH2O and again centrifuged 319 
at 2,500 g and 4°C for 10 min. The myofibrillar protein was solubilized by adding 1 mL of 0.3 320 
M NaOH and heating for 30 min at 50°C with samples being vortexed every 10 min. Samples 321 
were then centrifuged for 10 min at 9,500 g and 4°C, the supernatant containing the myofibrillar 322 
protein was kept and the collagen protein pellet was discarded. The myofibrillar proteins were 323 
precipitated by the addition of 1 mL of 1 M PCA and spun at 700 g and 4°C for 10 min. 324 





mL of 6 M HCL at 110°C. The free amino acids from the hydrolyzed myofibrillar protein pellet 326 
were dried under a nitrogen stream while being heated at 120°C. The free amino acids were 327 
subsequently dissolved in 25% acetic acid solution and passed over cation exchange AG 50W-328 
X8 resin columns (mesh size: 100-200, ionic form: hydrogen; Bio-Rad Laboratories, Hercules, 329 
CA) and eluted with 2 M NH4OH. Following this the eluted amino acids were dried and the 330 
purified amino acids were derivatized to their N(O,S)-ethoxycarbonyl ethyl esters (36). The 331 
derivatized amino acids were measured using a gas-chromatograph-isotope ratio mass 332 
spectrometer (GC-IRMS; Thermo Fisher Scientific, MAT 253; Bremen, Germany) equipped 333 
with a pyrolysis oven and a 60m DB-17MS column (no. 122-4762; Agilent, Wilmington, USA) 334 
and a 5 m precolumn. Ion masses 2 and 3 were analyzed to determine the 2H/1H ratios of muscle 335 
protein-bound alanine. A series of known standards was used to assess the linearity of the mass 336 
spectrometer and to control for the loss of tracer. 337 
 338 
Calculations 339 
Myofibrillar protein fractional synthesis rates (FSR) were calculated based on the incorporation 340 
of [2H] alanine into myofibrillar protein and the mean free plasma [2H] alanine enrichment 341 
throughout the immobilization period as a precursor. FSR was calculated using the standard 342 
precursor-product method expressed as daily rates as follows:  343 
89:	(% · 	day%&) = ? @'( −	@'&@)*+,-*./* 	B	/
C B	100 344 
where Em1 and Em2 are the myofibrillar muscle protein-bound enrichments on day 0 and 3. 345 
Eprecursor represents mean plasma free [2H] alanine enrichment (mean enrichment between day 346 
0-3). t represents the time between biopsies (day 0-3). FSRs were calculated in both legs 347 








All data are presented as means±SEM and all statistical analyses were conducted in GraphPad 352 
Prism version 7.0 (GraphPad Software, San Diego, CA, USA). The study sample size was 353 
based on a previously reported one week muscle disuse dietary controlled intervention in 354 
healthy young males (37). A sample size of 33 (11 per group) was anticipated to detect a 0.3% 355 
difference between HIGH, LOW and NO protein intakes groups on M. quadriceps muscle mass 356 
(SD=0.3, 80% power, α=0.05). A two-way repeated measures ANOVA with leg (control vs 357 
immobilized; treated as the repeated factor) and group (HIGH, LOW and NO) as factors were 358 
used to compare MyoPS rates. Three-way repeated measures ANOVAs (time [pre vs post], leg 359 
[control vs immobilized] and group [HIGH, LOW and NO] as factors, with time and leg 360 
considered as repeated factors) were used to compare M. quadriceps volume and isometric, 361 
concentric and eccentric leg strength and unilateral leg V̇O2peak data. A two-way repeated 362 
measures ANOVA with group (HIGH, LOW and NO) and time (habitual vs pre vs during 363 
immobilization) as factors was used to assess for differences in dietary intake parameters. Two-364 
way repeated measures (time) ANOVAs were used to assess how physical activity and plasma 365 
2H-alanine enrichments differed between groups from pre to during immobilization. For all 366 
ANOVAs, data were checked and no ANOVA model assumptions were violated, when a 367 
significant interaction was found Bonferroni post-hoc tests were applied to locate individual 368 








Physical activity and diet  373 
Table 1 displays participants’ characteristics and habitual dietary intakes, and Table 2 depicts 374 
dietary intake parameters and physical activity during the dietary controlled period for 5 days 375 
preceding (pre) and during the 3 day immobilization period. There were no significant 376 
differences in habitual energy or macronutrient intake or habitual physical activity levels 377 
between the groups (P>0.05). Light, vigorous and total physical activity significantly reduced 378 
from pre to during immobilization (time effects; all P<0.05) and to a similar extent (time x 379 
group interaction effects; all P>0.05) across groups. Moderate physical activity significantly 380 
declined in the HIGH and NO protein group only (P<0.05). As expected, all dietary parameters 381 
were identical across groups during the pre-immobilization dietary controlled period. By 382 
design, energy intake was equivalent across groups during immobilization, but dietary protein 383 
intake differed (group, time and group x time effects; all P<0.001) such that HIGH was greater 384 
than LOW and NO (both; P<0.001) and LOW was greater that NO (P<0.001). This resulted in 385 
differences in CHO intake across groups (group, time and group x time effects; all P<0.001) 386 
where HIGH was lower than NO (P<0.001) and LOW (P<0.05), with the NO group also having 387 
higher CHO intake than LOW (P<0.001). There were no significant differences between 388 
groups for fat intake during immobilization (group and the group x time effects; both P>0.05, 389 
time effect; P<0.001). (Fat intake [En%] was significantly reduced from pre to during 390 
immobilization in the NO group [P<0.05]). 391 
 392 
M. quadriceps muscle volume 393 
M. quadriceps muscle volumes calculated from MRI are displayed in Figure 2. There were no 394 





immobilization (group x leg interaction effect, P>0.05) (control leg; HIGH = 1412±85 cm3, 396 
LOW = 1448±106 cm3, NO = 1495±71 cm3, immobilized leg; HIGH = 1430±82 cm3, LOW = 397 
1439±105 cm3, NO = 1499±83 cm3). The M. quadriceps muscle volume of the control leg was 398 
unaffected by immobilization (P>0.05). M. quadriceps volume of the immobilized leg reduced 399 
significantly during immobilization (leg x time; P<0.001) by 2.3±0.4, 2.7±0.2 and 2.0±0.4 % 400 
in the HIGH (pre = 1430±82 to post immobilization = 1396±81 cm3, P<0.001), LOW (pre = 401 
1439±105 to post immobilization = 1400±101 cm3, P<0.001) and NO (pre = 1499±83 to post 402 
immobilization = 1469±81 cm3, P<0.05) groups, respectively (Figure 2B); however, these 403 
changes did not differ across groups (Figure 2B) (group x time and group x leg x time 404 
interactions; P>0.05).   405 
 406 
Muscle strength and single leg cycling V̇O2peak 407 
M. quadriceps and M. hamstrings muscle strength data are displayed in Figures 3 and 4, 408 
respectively. There were no significant differences in any contraction type for the M. 409 
quadriceps or M. hamstrings muscle strength between legs or between groups pre 410 
immobilization (group x leg interaction effect, P>0.05). No parameter of strength was altered 411 
throughout the experiment in the control leg for either the M. quadriceps or M. hamstrings 412 
muscles (P>0.05) and there were no significant differences between groups (P>0.05). 413 
Immobilization decreased M. quadriceps maximal isometric (HIGH = by 24±8%, LOW = by 414 
24±6%, NO = by 26±5%; time x leg effect; P<0.001), concentric (HIGH = by 23±8%, LOW 415 
= by 22±6%, NO = by 25±4%; time x leg effect; P<0.001) and eccentric (HIGH = by 16±7 %, 416 
LOW = by 18±8 %, NO = by 23±6 %; time x leg effect; P<0.001) strength to a similar extent 417 
across groups (group x leg interaction; P>0.05 for all 3 contraction types). In contrast, 418 
immobilization only reduced M. hamstrings maximal concentric strength (HIGH = by 7±2 %, 419 





between groups (group x leg interaction; P>0.05), whereas M. hamstrings maximal isometric 421 
and eccentric strength were unaffected by immobilization (all main and interaction effects; 422 
P>0.05, except hamstring isometric time effect; P<0.01). Unilateral V̇O2peak (Figure 5) was 423 
not affected by immobilization (P>0.05), group (P>0.05) in either leg (interactions all; 424 
P>0.05).  425 
 426 
Plasma free 2H alanine precursor pool enrichment 427 
Plasma free [2H] alanine enrichments (Figure 6) were 2.4±0.1, 2.4±0.1 and 2.3±0.1 mole 428 
percent excess (MPE) at the start of immobilization in the HIGH, LOW and NO groups, 429 
respectively, and tended (time effect; P=0.06) to increase post immobilization. However, there 430 
were no significant differences in plasma free [2H] alanine enrichments between groups 431 
(P>0.05). 432 
 433 
Daily myofibrillar protein synthesis rates 434 
Myofibrillar protein bound [2H] alanine enrichments increased pre- to post- immobilization 435 
(main effect of time; P<0.001), and showed differences between legs (main effect of group; 436 
P<0.001) with the control leg increasing more than the immobilized leg (group x time 437 
interaction; P<0.001). After the 3 day immobilization period myofibrillar protein bound [2H] 438 
alanine enrichments increased by 44±4, 35±4 and 39±5 % more in the control compared with 439 
the immobilized leg in the HIGH (control leg to 0.1149±0.0045 MPE; immobilized leg to 440 
0.0797±0.0024 MPE), LOW (control leg to 0.1191±0.0057 MPE; immobilized leg to 441 
0.0885±0.0036 MPE) and NO (control leg to 0.1041±0.0041 MPE; immobilized leg to 442 
0.0755±0.0031 MPE) groups respectively (data not shown). There were no significant 443 
differences between groups (P>0.05), or any group interactions (all P>0.05) such that dietary 444 





Daily myofibrillar protein FSRs (%·d-1) during immobilization, calculated separately in the 446 
control and immobilized legs using mean plasma free [2H] alanine enrichments as the precursor 447 
pool, are displayed in Figure 7. Daily myofibrillar protein FSRs were 30±2, 26±3 and 27±2 % 448 
lower in the immobilized compared with the control leg in the HIGH (1.55±0.05 vs 1.08±0.04 449 
%·d-1), LOW (1.57±0.10 vs 1.16±0.06 %·d-1) and NO (1.40±0.08 vs 1.03±0.07 %·d-1) groups 450 

























We assessed the impact of graded intakes of daily dietary protein during a short-term (3 day) 472 
period of muscle disuse (knee immobilization) in healthy young men on daily myofibrillar 473 
protein synthesis (MyoPS) rates, muscle mass and function. We report that 3 days of 474 
immobilization resulted in a considerable decline in daily MyoPS rates and loss of M. 475 
quadriceps volume and leg muscle strength. However, none of these muscle deconditioning 476 
responses to immobilization were modulated by daily dietary protein intake, despite our design 477 
spanning a virtual absence of protein through to relatively high intakes.   478 
Dietary protein ingestion transiently stimulates MyoPS rates for 2-5 h (38). As such, the 479 
repeated postprandial stimulation at each meal contributes considerably to daily, 24 h MyoPS 480 
rates and, thus, muscle mass maintenance. We recently demonstrated that a major physiological 481 
driver of muscle loss during short-term disuse is a considerable decline in daily, free-living 482 
MyoPS rates (4). Importantly, in that work we reported that disuse lowered daily MyoPS rates 483 
and consequently induced muscle atrophy despite participants (self) reporting habitual protein 484 
intakes double that of the daily UK RDA (32) (i.e. 1.6 g·kg bm·d-1) and in line with current 485 
recommendations to limit muscle disuse atrophy (10, 14, 33). However, this study was not 486 
conducted under dietary controlled conditions, nor did we compare groups according to protein 487 
intakes, and thus in the present work we aimed to establish the role of daily dietary protein 488 
intake on daily MyoPS rates and muscle loss during disuse. We recreated the relatively high 489 
habitual protein intake previously observed (which was also in line with the habitual protein 490 
intakes of the current participants; see Table 2) and habituated all participants to this diet for 491 
five days prior to immobilization. This allowed the application of a dose-response approach 492 
during the immobilization period only, where a control group maintained the same intake, one 493 
group consumed a diet virtually devoid of protein, and another group a sub-optimal amount 494 





(4), immobilization lowered MyoPS rates by ~28% (or ~9%·d-1) compared with the control 496 
legs. However, contrary to our hypothesis, this decline was comparable across the groups, with 497 
the higher, low and negligible protein intakes resulting in 30, 26, and 27% lower MyoPS rates, 498 
respectively, in the immobilized compared with control legs. As well as the considerable 499 
difference in total protein intakes across groups, these data also occurred in the face of the 500 
control group being provided their daily protein intake equally across four meals (breakfast, 501 
lunch, dinner, pre-bed; resulting in ~28 g protein per meal) each separated by ~4 h. We had 502 
reasoned such an approach would result in sufficient protein per meal (12, 31) and 503 
appropriately timed (13, 39, 38) to maximise daily MyoPS rates. It would be remiss of us not 504 
to mention that significant differences in daily MyoPS rate across groups also did not occur in 505 
the non-immobilized leg. It is likely that this represents a type-2 error given that the NO protein 506 
group displayed (numerically) lower daily MyoPS rates coupled with a numerical loss 507 
(compared with a numerical gain in the other groups) of muscle mass. 508 
In line with the lack of effect of dietary protein intake on daily MyoPS rates, we also observed 509 
no impact on muscle mass loss during disuse (Figure 2). We have recently shown that leg 510 
immobilization results in substantial atrophy of the M. quadriceps within two days (11). In line 511 
with those data, and previous reports (4, 5, 15, 40), we observed a ~2.4% (i.e. 0.8%·d-1) decline 512 
in M. quadriceps volume following 3 days of immobilization. However, atrophy was 513 
comparable across the dietary intervention groups with the high, low and zero protein intake 514 
groups’ M. quadriceps volume declining by 2.3 (~0.8%·d-1), 2.7 (~0.9%·d-1) and 2.0% 515 
(~0.7%·d-1), respectively. These data were also consistent with the lack of effect of dietary 516 
protein intake on the decline in a wide array of muscle function tests following immobilization 517 
(Figures 5 and 6). Indeed, with the exception of concentric contractions (2%·d-1 decline), M. 518 
hamstrings strength was remarkably resistant to disuse induced declines, whereas M. 519 





all declined at rates in line with the literature (40, 41). Though the numerical decrease in single 521 
leg V̇O2peak seen with immobilization was not significant (Figure 7), comparable effects were 522 
seen across groups. Accordingly, our data conclusively show that the decline in muscle 523 
function during short-term disuse is rapid, but not modulated by dietary protein intake. 524 
Previous studies have also found that manipulating protein intake during disuse does not 525 
modulate the rate of muscle disuse atrophy. For example, protein supplementation studies 526 
which have increased protein intakes to; 1.6 (vs 1.1) g·kg bm·d-1 during 5 days of 527 
immobilization in older men (3); 1.3 (vs 1.0) g·kg bm·d-1 during 2 weeks of immobilization in 528 
young men (42); and to 1.6 (vs 1.0) g·kg bm·d-1 during 29 days of bed-rest in young men and 529 
women (20), have all shown no protective effect on muscle mass. Taken together, therefore, it 530 
would seem that dietary protein consumption within ‘normal ranges’ (i.e. ≤1.6 g·kg bm·d-1) 531 
during disuse does not modulate the rate of muscle loss. We have reasoned previously that such 532 
findings may be due to control groups also consuming adequate protein (3). However, our data 533 
refute this notion with the novel observation that daily MyoPS rates and muscle loss are still 534 
not modulated even when relatively high, evenly spaced protein intakes are compared with low 535 
or negligible protein diets. Collectively, these studies’ findings may be explained by the 536 
reduced MPS response to each dietary protein meal that occurs consequent with disuse (i.e. 537 
‘anabolic resistance’; (5, 35, 43)). Our data extend on the concept of disuse induced anabolic 538 
resistance by implying that this phenomenon manifests virtually immediately (given the short 539 
time frame of disuse), is not overcome by modest increases in protein intake, and is not 540 
exacerbated by dramatic reductions in protein intake.  541 
Research where specific essential amino acid (EAA) or leucine supplementation has been 542 
applied during a period of disuse has generally (17, 18, 37, 44), but not always (6) attenuated 543 
muscle loss. It is possible that this apparent discrepancy with protein supplementation studies 544 





That is, extrapolating total daily protein intakes from these supplementation studies suggests 546 
the equivalent of ~87-158 (1.2-1.9 g·kg bm·d-1) g total protein was consumed in the treatment 547 
conditions, and thus generally higher than the present and previous data concerning protein 548 
manipulation. Alternatively, the specific provision of high dose EAA and/or leucine may have 549 
had the capacity to overcome/compensate for muscle anabolic resistance more effectively than 550 
the present work. In support, such supplementation studies have provided daily EAA and 551 
leucine intakes of ~43-88 and ~15-19 g per day, respectively (17, 18, 37, 44), compared with 552 
~51 and ~8 g in the present work, or ~19-50 and ~3-10 g in previous protein manipulation 553 
studies ineffective at attenuating muscle disuse atrophy (3, 19, 20). This would imply that the 554 
availability of amino acids per se is not limiting to MPS during disuse, but rather a dramatic 555 
increase in the threshold required for EAA/leucine to stimulate intracellular anabolic signalling 556 
pathways rates occurs. The inference therefore would be that maximising selective intracellular 557 
transport of these key amino acids (rather than raising global amino acid availability) is the 558 
prudent goal during disuse. However, such a notion clearly warrants further research, especially 559 
given not all leucine supplementation studies have been successful at attenuating muscle disuse 560 
atrophy (6). Additionally, the model of disuse (i.e. single limb immobilization vs whole body 561 
bedrest) is a further important consideration. The amount of inactive tissue will undoubtedly 562 
affect amino acid availability during disuse, and could therefore conceivably contribute 563 
towards discrepancies across studies or nutritional strategies depending on the nature of disuse. 564 
It may be that future nutritional strategies may be more effective by focussing on sensitising 565 
the intracellular anabolic signalling pathways (rather than increasing the stimulus), which 566 
appears to explain the proposed beneficial effects of prolonged fish oil supplementation on 567 
MPS rates and muscle mass maintenance in ageing (45, 46) and disuse (7). 568 
In conclusion, graded dietary protein intakes of 0.15, 0.5 or 1.6 g·kg bm·d-1 did not influence 569 





immobilization. This study is the first to evaluate the role of dietary protein intake per se under 571 
controlled dietary conditions on the rate of skeletal muscle deconditioning during short-term 572 
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Table 1. Participants’ characteristics and habitual diet. 
 HIGH LOW NO 
 
Age (y) 22±1 22±1 20±1 
Height (m) 1.78±0.08 1.74±0.09 1.79±0.09 
Body mass (kg) 72±1 70±1 72±1 
BMI (kg·m-2) 23±1 23±1 23±1 
Body fat (%) 15±1 15±1 17±1 
Lean mass (kg) 61±1 60±1 60±1 
Systolic blood pressure (mmHg) 126±1 124±1 124±1 
Diastolic blood pressure (mmHg) 76±1 71±1 76±1 
Mean arterial blood pressure (mmHg) 94±1 90±1 93±1 








Protein intake (g·d-1) 
Protein intake (g·kg bm·d-1) 











CHO intake (g·d-1) 







Fat intake (g·d-1) 







Values represent means±SEM, n=11 per group. Data were statistically analyzed with a one 








Table 2. Dietary intake and physical activity levels during dietary controlled periods pre and during a 3 day period of unilateral knee 
immobilization. 
                  HIGH                       LOW       NO 
 Pre During  Pre During  Pre During  














Protein intake (g·d-1) 
Protein intake ( g·kg bm·d-1) 
Protein intake (En%) 
Protein per meal (g) 
116±4 
1.6±0.1 






















10±0.4* a, b 
0.14±0.1* a, b 
1.4±0.03* a, b 
3±0.1* a, b 
CHO intake (g·d-1) 











525±13* a, b 
71±2* a, b 
Fat intake (g·d-1) 












23±1* a, b 









Values represent means±SEM, n=11 per group. Data were analyzed by using a two-way repeated measures ANOVA (with time and group as 
factors). *=significant difference from pre immobilization value, P<0.001, a = significant difference from HIGH group during immobilization 
P<0.05, b = significant difference from LOW group during immobilization P<0.001. En% = % of total energy intake. Pre denotes the 5 day 












Moderate physical activity (h·d-1) 2.1±0.2 1.6±0.2* 2.2±0.3 1.7±0.2 3.0±0.5 1.5±0.2* 
Vigorous physical activity (h·d-1) 



















Figure 1. Study protocol. Thirty-three healthy young males underwent 3 days of unilateral leg 
immobilization via knee brace. MRI, Magnetic resonance imaging. D2O, deuterated water 
ingestion. Activity, physical activity measured continuously by GENEactiv wrist watch 
accelerometry. Diet, all participants underwent 5 days of fully controlled pre-immobilization 
diet relatively high in dietary protein (1.6 g·kg bm·d-1) before being randomized into three 
groups of varying protein intake HIGH (1.6 g·kg bm·d-1), LOW (0.5 g·kg bm·d-1) and NO 
(0.15 g·kg bm·d-1) for the 3 day immobilization period. Blood, venous blood sample collection. 
Arrows represent M. vastus lateralis muscle biopsies, (i.e. taken from the immobilized leg only 
at pre-immobilization and both control and immobilized legs post-immobilization). Strength, 
unilateral maximal isometric, concentric and eccentric contractions of both the M. quadriceps 
and M. hamstrings measured by isokinetic dynamometry. V̇O2peak, single leg peak oxygen 
uptake was measured using a ramp cycling test to exhaustion. Control and immobilized legs 
completed all strength and aerobic capacity tests separately. 
 
Figure 2. M. quadriceps muscle volume of the control and immobilized legs pre and post 3 
days of unilateral leg immobilization where participants consumed a fully controlled energy 
balanced diet containing a HIGH (n=11; 1.6 g·kg bm·d-1), LOW (n=11; 0.5 g·kg bm·d-1) or 
NO (n=11; 0.15 g·kg bm·d-1) dietary protein content (A). A three-way repeated measures 
ANOVA (leg [control vs immobilized] x time [pre vs post] x group [HIGH, LOW and NO] as 
factors, with time and leg considered as repeated factors) was conducted to assess for statistical 
differences. Main effect of leg P>0.05, group P>0.05 and time P<0.001. Leg x group 
interaction P>0.05, leg x time interaction P<0.001, group x time interaction P>0.05, leg x 





differences; *** and * denotes a significant difference from pre immobilization within the same 
group at P<0.001 and P<0.05, respectively. B expresses the relative difference in M. 
quadriceps volume between the control and immobilized legs for HIGH, LOW and NO groups. 
Data were analyzed by a two-way repeated measures ANOVA with leg (control vs 
immobilized; treated as the repeated factor) and group (HIGH vs LOW vs NO) as factors. Main 
effect of leg P<0.001, group P>0.05, leg x group interaction was P<0.05. Bonferroni post tests 
were conducted to locate individual differences; * and *** denote a significant difference from 
pre immobilization within the same group at P<0.05 and P<0.001, respectively. Data presented 
are means±SEM.  
 
Figure 3. M. quadriceps muscle strength assessed by isokinetic dynamometry. Maximal 
isometric (3-repetition average) (A), isokinetic concentric (C) and isokinetic eccentric (E) (both 
5-repetition average) M. quadriceps strength for the control and immobilized legs pre- and 
post- immobilization for the three groups HIGH (n=11; 1.6 g·kg bm·d-1), LOW (n=11; 0.5 g·kg 
bm·d-1) and NO (n=11; 0.15 g·kg bm·d-1). Data were analyzed by three-way repeated measures 
ANOVA (with leg [control vs immobilized] x time [pre vs post] x group HIGH, LOW and NO] 
as factors, with time and leg considered as repeated factors). A, C, and E all showed no main 
effect of group (P>0.05), but for isometric and concentric M. quadriceps strength a main effect 
of leg was detected P<0.05, but for eccentric the main effect of leg was P>0.05. For all three 
exercises (graphs A, C and E) the main effect of time was P<0.001. The group x leg and group 
x time interactions were P>0.05 for 3 graphs (A, C and E), the leg x time interactions were 
P<0.001 for all 3 graphs (A, C and E). The group x leg x time interactions were P>0.05 for all 
three graphs. Graphs B, D and F show the relative change in maximal isometric, concentric 
and eccentric M. quadriceps strength respectively, for the control and immobilized leg and for 





with leg (control vs immobilized; treated as the repeated factor) and group (HIGH, LOW and 
NO) as factors. The main effect of group was P>0.05 for all 3 graphs (B, D, F), the main effect 
of leg was P<0.05 for isometric (B) and eccentric (E) exercises and P<0.01 for concentric (D). 
* and ** denote the main effect of leg at P<0.05 and P<0.01 level respectively. The group x 
leg interaction effects were P>0.05 for all 3 exercises (graph B, D, F). Data are means±SEM. 
 
Figure 4. M. hamstrings muscle strength assessed by isokinetic dynamometry. Maximal 
isometric (3-repetition average) (A), isokinetic concentric (C) and isokinetic eccentric (E) (both 
5-repetition average) M. hamstrings strength, for the control and immobilized legs pre- and 
post- immobilization for three groups HIGH (n=11; 1.6 g·kg bm·d-1), LOW (n=11; 0.5 g·kg 
bm·d-1) and NO (n=11; 0.15 g·kg bm·d-1). Data were analyzed by three-way repeated measures 
ANOVA (with leg [control vs immobilized] x time [pre vs post] x group [HIGH, LOW and 
NO] as factors, with time and leg considered as repeated factors). A, C and E all showed no 
main effect of leg P>0.05, main effect of time was P>0.05 for concentric (C) and eccentric (E), 
but P<0.01 for isometric (A). Group x leg and group x time interactions were P>0.05 for 3 
graphs (A, C and E), the leg x time interactions were P>0.05 for isometric (A) and eccentric 
(E), but P<0.05 for concentric (C). The group x leg x time interactions were P>0.05 for all 
three graphs. Graphs B, D and F show the relative change in maximal isometric, concentric 
and eccentric M. hamstrings strength respectively, for the control and immobilized leg and for 
the HIGH, LOW and NO groups. Data were analyzed by two-way repeated measures ANOVA 
with leg (control vs immobilized; treated as the repeated factor) and group (HIGH, LOW and 
NO) as factors. The main effect of group was P>0.05 for all 3 graphs (B, D, F), the main effect 
of leg was P<0.05 for concentric (C) and P>0.05 for eccentric (E) exercises and concentric 
(D). * denotes the main effect of leg P<0.05. The group x leg interaction effects were P>0.05 






Figure 5. V̇O2peak achieved during a unilateral cycling ramp test. The graph expresses data 
for both the control and immobilized leg and for both pre- and post- immobilization. Data were 
analysed by three-way repeated measures ANOVA (with leg [control vs immobilized] x time 
[pre vs post] x group [HIGH, LOW and NO] as factors, with time and leg considered as 
repeated factors). Main effect of both group and leg were P>0.05, but time was P<0.05. The 
group x time, group x leg and leg x time interactions were all P>0.05, the group x time x leg 
interaction was P>0.05. Data were analyzed by two-way ANOVA with leg and group as 
factors. Main effects of group, leg were both P>0.05, the group x time interaction was P>0.05. 
Data are means±SEM; n=11 per group. 
 
Figure 6. Plasma free 2H-alanine (MPE) enrichments pre and post a 3 day period of unilateral 
knee immobilization where participants consumed a fully controlled energy balance diet 
containing a HIGH (n=11; 1.6 g·kg bm·d-1), LOW (n=11; 0.5 g·kg bm·d-1) and NO (n=11; 0.15 
g·kg bm·d-1) dietary protein content. Data were analyzed using a two-way repeated measures 
ANOVA with group (HIGH vs LOW vs NO) and time (pre vs post immobilization) as factors. 
Main effect of group P>0.05, time P>0.05 and group x time interaction P>0.05. Data are 
means±SEM. 
 
Figure 7. Daily myofibrillar fractional synthesis rates (FSR; %·d-1) over a 3 day 
immobilization period via unilateral knee immobilization calculated from the plasma 2H-
alanine precursor pool, where participants consumed a fully controlled energy balance diet 
containing a HIGH (n=11; 1.6 g·kg bm·d-1), LOW (n=11; 0.5 g·kg bm·d-1) and NO (n=11; 0.15 
g·kg bm·d-1) dietary protein content. Data were assessed by two-way repeated measures 





and group (HIGH vs LOW vs NO) as factors. Main effect of leg P<0.001 (***), group P>0.05, 
leg x group interaction P>0.05. B expresses the difference in daily myofibrillar fractional 
synthesis rates between the control and immobilized leg for the three groups. Data were 







































































































































































































































Control leg Immobilized leg
Group>0.05
Leg>0.05
Time<0.01
GxLxT>0.05
 
 
 
 
Figure 6 
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